StockData
IGC Pharma, Inc. logo

IGC Pharma, Inc. (IGC) stock

IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3019% above fair value
$0.19+0.01 (+7.37%)

Close on Nov 17, 2026Market cap $19.43MP/E –Yield –

IGC Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

IGC Pharma's market cap was $20.37M on Nov 11, 2026, against $29.34M a year earlier. Over the last 5 years it ranged from $15.39M to $54.12M, with a median of $25.49M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$20.37M-21.3%
2025Dec 31, 2025$25.88M+0.5%
2024Dec 31, 2024$25.75M+44.3%
2023Dec 29, 2023$17.84M+5.7%
2022Dec 30, 2022$16.88M-66.1%
2021Dec 31, 2021$49.84M-22.6%
2020Dec 31, 2020$64.43M+158.5%
2019Dec 31, 2019$24.93M+160.0%
2018Dec 31, 2018$9.59M+36264.7%
2017Dec 29, 2017$26.37K+317.4%
2016Dec 30, 2016$6.32K+72.3%
2015Dec 31, 2015$3.67K-52.6%
2014Dec 31, 2014$7.73K+5.5%
2013Dec 31, 2013$7.33K-7.5%
2012Dec 31, 2012$7.92K–

More IGC Pharma figures

See a number that looks wrong?